Clinical trials
Enrolling by invitation trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
200 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2013 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2018 | 6 |
| 2019 | 9 |
| 2020 | 3 |
| 2021 | 13 |
| 2022 | 18 |
| 2023 | 27 |
| 2024 | 37 |
| 2025 | 54 |
| 2026 | 27 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Enrolling by invitation | 200 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| The Wellcome Sanger Institute | 7 |
| King's College London | 6 |
| Novo Nordisk A/S | 6 |
| University of Oxford | 5 |
| University of Ulster | 5 |
| Aston University | 4 |
| Imperial College London | 4 |
| Quadram Institute Bioscience | 4 |
| Sanofi | 4 |
| BioMarin Pharmaceutical | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasms | 8 |
| Genetic Diseases, Inborn | 7 |
| Cardiovascular Diseases | 6 |
| Angioedemas, Hereditary | 5 |
| Diabetes Mellitus, Type 2 | 5 |
| Obesity | 5 |
| Bone Diseases | 4 |
| Epilepsy | 4 |
| Muscular Dystrophy, Duchenne | 4 |
| Musculoskeletal Diseases | 4 |
Trials
Showing 1 to 25 of 200. Each trial links to its page on Pharma Observatory.
100 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.